Oculocutaneous albinism type 1B associated with a functionally significant tyrosinase gene polymorphism detected with Whole Exome Sequencing

References

• Dolinska MB, Kovaleva E, Backlund P, Wingfield PT, Brooks BP, Sergeev YV. Albinism-causing mutations in recombinant human tyrosinase alter intrinsic enzymatic activity. PLoS One. 2014 Jan 2;9(1):e84494. doi:10.1371/journal.pone.0084494
   PubMed Web of Science ®Google Scholar
• Noh H, Lee SJ, Jo HJ, Choi HW, Hong S, Kong KH. Histidine residues at the copper-binding site in human tyrosinase are essential for its catalytic activities. J Enzyme Inhib Med Chem. 2020 Jan 1;35(1):726–32. doi:10.1080/14756366.2020.1740691
   PubMed Web of Science ®Google Scholar
• Lai X, Wichers HJ, Soler‐Lopez M, Dijkstra BW. Frontispiece: structure and function of human tyrosinase and tyrosinase‐related proteins. Chem Eur J. 2018 Jan 2;24(1). doi:10.1002/chem.201880164
   Web of Science ®Google Scholar
• Mander L, Liu HW. Comprehensive natural products II: chemistry and biology. Vols. 8, 2010. Oxford (UK): Elsevier; 2010. p. 489–545.
   Google Scholar
• Wei A, Yang X, Lian S, Li W. Implementation of an optimized strategy for genetic testing of the Chinese patients with oculocutaneous albinism. J Dermatol Sci. 2011 May 1;62(2):124–27. doi:10.1016/j.jdermsci.2011.02.009
   PubMed Web of Science ®Google Scholar
• Monfermé S, Lasseaux E, Duncombe-Poulet C, Hamel C, Defoort-Dhellemmes S, Drumare I, Zanlonghi X, Dollfus H, Perdomo Y, Bonneau D, et al. Mild form of oculocutaneous albinism type 1: phenotypic analysis of compound heterozygous patients with the R402Q variant of the TYR gene. Br J Ophthalmol. 2019 Sep 1;103(9):1239–47. doi:10.1136/bjophthalmol-2018-312729.
   PubMed Web of Science ®Google Scholar
• Norman CS, O’Gorman L, Gibson J, Pengelly RJ, Baralle D, Ratnayaka JA, Griffiths H, Rose-Zerilli M, Ranger M, Bunyan D, et al. Identification of a functionally significant tri-allelic genotype in the Tyrosinase gene (TYR) causing hypomorphic oculocutaneous albinism (OCA1B). Sci Rep. 2017 Jun 30;7(1):1–9. doi:10.1038/s41598-017-04401-5.
   PubMedGoogle Scholar
• Bienert S, Waterhouse A, de Beer TA, Tauriello G, Studer G, Bordoli L, Schwede T. The SWISS-MODEL repository – new features and functionality. Nucleic Acids Res. 2017 Jan 4;45(D1):D313–9. doi:10.1093/nar/gkw1132
   PubMed Web of Science ®Google Scholar
• Lai X, Wichers HJ, Soler‐Lopez M, Dijkstra BW. Structure of human tyrosinase related protein 1 reveals a binuclear zinc active site important for melanogenesis. Angew Chem Int Ed. 2017 Aug 7;56(33):9812–15. doi:10.1002/anie.201704616
   PubMed Web of Science ®Google Scholar
• Schrödinger LLC The PyMOL molecular graphics system. Version, 2.0. 2010.
   Google Scholar
• Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, Collins RL, Laricchia KM, Ganna A, Birnbaum DP, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020 May;581(7809):434–43. doi:10.1038/s41586-020-2308-7.
   PubMed Web of Science ®Google Scholar
• Gershoni-Baruch R, Rosenmann A, Droetto S, Holmes S, Tripathi RK, Spritz RA. Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel. Am J Hum Genet. 1994 Apr;54(4):586.
   PubMed Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015 May;17(5):405–23. doi:10.1038/gim.2015.30.
   PubMed Web of Science ®Google Scholar
• Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014 Apr;11(4):361–62. doi:10.1038/nmeth.2890.
   PubMed Web of Science ®Google Scholar
• Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012 Jul 1;40(W1):W452–7. doi:10.1093/nar/gks539
   PubMed Web of Science ®Google Scholar
• Quang D, Chen Y, Xie X. DANN: a deep learning approach for annotating the pathogenicity of genetic variants. Bioinformatics. 2015 Mar 1;31(5):761–63. doi:10.1093/bioinformatics/btu703
   PubMed Web of Science ®Google Scholar
• HA S, Gough J, Cooper DN, Stenson PD, Barker GL, Edwards KJ, Day IN, Gaunt TR. Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Hum Mutat. 2013 Jan;34(1):57–65. doi:10.1002/humu.22225.
   PubMed Web of Science ®Google Scholar
• Li Q, Wang K. InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. Am J Hum Genet. 2017 Feb 2;100(2):267–80. doi:10.1016/j.ajhg.2017.01.004
   PubMed Web of Science ®Google Scholar
• Chaki M, Sengupta M, Mondal M, Bhattacharya A, Mallick S. Molecular and functional studies of tyrosinase variants among Indian oculocutaneous albinism type 1 patients. J Investig Dermatol. 2011;131(1):260–62. doi:10.1038/jid.2010.274
   PubMed Web of Science ®Google Scholar
• King RA, Witkop CJ. Detection of heterozygotes for tyrosinase-negative oculocutaneous albinism by hairbulb tyrosinase assay. Am J Hum Genet. 1977 Mar;29(2):164.
   PubMed Web of Science ®Google Scholar
• Van Dorp DB, Van Haeringen NJ, Glasius E. Evaluation of hairbulb incubation test and tyrosinase assay in the classification of albinism. Ophthalmic Paediatr Genet. 1982 Jan 1;1(3):189–200. doi: 10.3109/13816818209036033.
   Web of Science ®Google Scholar
• Chiang PW, Drautz JM, Tsai AC, Spector E, Clericuzio CL. A new hypothesis of OCA1B. Am J Med Genet A. 2008;146(22):2968–70. doi:10.1002/ajmg.a.32539
   Google Scholar
• Ray K, Chaki M, Sengupta M. Tyrosinase and ocular diseases: some novel thoughts on the molecular basis of oculocutaneous albinism type 1. Prog Retin Eye Res. 2007 Jul 1;26(4):323–58. doi:10.1016/j.preteyeres.2007.01.001
   PubMed Web of Science ®Google Scholar
• Kalahroudi VG, Kamalidehghan B, Kani AA, Aryani O, Tondar M, Ahmadipour F, Chung LY, Houshmand M. Two novel tyrosinase (TYR) gene mutations with pathogenic impact on oculocutaneous albinism type 1 (OCA1). PLoS One. 2014 Sep 12;9(9):e106656. doi:10.1371/journal.pone.0106656
   PubMed Web of Science ®Google Scholar
• Tripathi RK, Strunk KM, Giebel LB, Weleber RG, Spritz RA. Tyrosinase gene mutations in type I (tyrosinase‐deficient) oculocutaneous albinism define two clusters of missense substitutions. Am J Med Genet. 1992 Jul 15;43(5):865–71. doi:10.1002/ajmg.1320430523
   PubMed Web of Science ®Google Scholar
• Oetting WS, Witkop CJ Jr, Brown SA, Colomer R, Fryer JP, Bloom KE, King RA. A frequent tyrosinase gene mutation associated with type IA (tyrosinase-negative) oculocutaneous albinism in Puerto Rico. Am J Hum Genet. 1993 Jan;52(1):17.
   PubMed Web of Science ®Google Scholar
• Chiang PW, Spector E, Tsai AC. Oculocutaneous albinism spectrum. Am J Med Genet A. 2009;149(7):1590–91. doi:10.1002/ajmg.a.32939
   Google Scholar
• Sulem P, Gudbjartsson DF, Stacey SN, Helgason A, Rafnar T, Magnusson KP, Manolescu A, Karason A, Palsson A, Thorleifsson G, et al. Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat Genet. 2007 Dec;39(12):1443–52. doi:10.1038/ng.2007.13.
   PubMed Web of Science ®Google Scholar
• Wei AH, Zang DJ, Zhang Z, Yang XM, Li W. Prenatal genotyping of four common oculocutaneous albinism genes in 51 Chinese families. J Genet Genomics. 2015 Jun 20;42(6):279–86. doi:10.1016/j.jgg.2015.05.001
   PubMed Web of Science ®Google Scholar